Results

Total Results: 708 records

Showing results for "drug".

21. PowerPoint Presentation (ppt file)
    www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/nhguide/4_TK2_T4-Common_Suspected_Infections_Tools_to_Improve_Communication_and_Decision_Making.ppt
    May 01, 2014 - * Quality Improvement for Antibiotic Prescribing Problems with taking antibiotics Drug resistance … vomiting, diarrhea Secondary infections: C difficile, yeast Allergic reactions: rash, anaphylaxis Drug … In developing countries, multi-drug resistant tuberculosis in an ever-increasing challenge. … The price of innovation: new estimates of drug development costs.  … Yet if antibiotic resistance does develop, it will limit the effective lifespan of the drug.

22. Antibiotic Stewardship Program (ASP) Development
    www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/antibiotic-use/long-term-care/program-dev-slides.pptx
    June 01, 2021 - No monitoring for drug-drug interactions. No followup to narrow therapy. … No monitoring for drug-drug interactions. No followup to narrow therapy. … improvement The team chooses to focus on 2 post-prescriptive opportunities for improvement Monitor for drug-drug … No monitoring for drug-drug interactions. No followup to narrow therapy. … Developing a Program 14 Baseline Data Monitor for drug-drug interactions.

23. CHIPRA 233: Section 3, Table 2, FDA Pregnancy Category Rating (pdf file)
    www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-233-hrob-section-3-table-2.pdf
    August 08, 2018 - Food and Drug Administration Pregnancy Category Rating Pregnancy Category Explanation Category … are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug … investigational or marketing experience or studies in humans, but potential benefits may warrant use of the drug … reaction data from investigational or marketing experience, and the risks involved in use of the drug

24. Event Investigation and Analysis Guide: Appendix A | Agency for Healthcare Research and Quality
    www.qualitymeasures.ahrq.gov/patient-safety/settings/hospital/candor/modules/guide4/apa.html
    August 01, 2022 - When the drug was brought into the facility, it was a different concentration from what had been used … There has been a drug shortage of the concentration that we typically use, and we had no choice but to … Our computer system is not connected to the National Drug Database, so we can’t simply scan the bottle … We have to enter every drug into our database manually. … In this case, the drug was entered as the wrong concentration.

25. Comparison Tables for Making Healthcare Safer Reports | Agency for Healthcare Research and Quality
    www.qualitymeasures.ahrq.gov/research/findings/making-healthcare-safer/comparison.html
    September 01, 2022 - ADEs: Harms Due to Diabetic Agents ADEs: Reducing Adverse Drug Events in Older Adults ADEs: Harms … Topics Patient Safety Practices  MHS I (2001) MHS II (2013) MHS III (2020) Computer Adverse Drug … Event Detection and Alerts Summary of Evidence (Not reviewed) (Not reviewed) Unit-Dose Drug … Summary of Evidence Update (Not reviewed) The Clinical Pharmacist's Role in Preventing Adverse Drug …   Teach-Back (Not reviewed) (Not reviewed) Summary of Evidence   ADEs: Reducing Adverse Drug

26. Declines in Hospital-Acquired Conditions (pdf file)
    www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/data/infographics/hac-rates-2019-updated.pdf
    January 01, 2019 - Hospital- Acquired Conditions National efforts to reduce hospital-acquired conditions such as adverse drug … Adverse Drug Events -28% CAUTI* -5% CLABSI+ -6% Clostridioides difficile Infections -37%

27. Behavioral Health Risk Assessment for Pregnant Women Measure Technical Specifications (pdf file)
    www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/perinatal/0085-tech-specs.pdf
    January 01, 2012 - following screenings at the first prenatal visit: screening for depression, alcohol use, tobacco use, drug … visit Tobacco use screening Patients who were screened for tobacco use* at the first visit Drug … use (illicit and prescription, over the counter) screening Patients who were screened for any drug … use, prescription drug use and over the counter drug use. … Illicit, Prescription and Over the Counter Drug Use ScreeningRisk Category/Assessment For the purposes

28. Ncinqtobaccousehelp-References (pdf file)
    www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/NCINQTobaccoUseHelp-References.pdf
    August 01, 2012 - CHIP-Program-Information/By-Topic/Early-Periodic-Screening-Diagnosis-Treatment.html National Institute on Drug … Screening for Drug Use in General Medical Settings: A Quick Reference Guide. NIH Pub No. 09-7384. … National Survey on Drug Use and Health (NSDUH). 2010 National Survey on Drug Use and Health data.

29. ADHD Behavior Therapy References (pdf file)
    www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-references.pdf
    August 12, 2012 - Silver Spring, MD: Food and Drug Administration, Center for Drug Evaluation and Research; 2004. … Silver Spring, MD: Food and Drug Administration, Center for Drug Evaluation and Research; 2004. … Mortality associated with attention- deficit hyperactivity disorder (ADHD) drug treatment: a retrospective … Drug Saf; 2009;32(11):1089-1110 McCarthy S, Cranswick N, Potts L, Taylor E, Wong IC. … Drug Saf. 2009;32(11):1089-1110 McGoey KE, DuPaul GJ, Haley E, Shelton TL.

30. References (pdf file)
    www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-references.pdf
    August 12, 2012 - Silver Spring, MD: Food and Drug Administration, Center for Drug Evaluation and Research; 2004. … Silver Spring, MD: Food and Drug Administration, Center for Drug Evaluation and Research; 2004. … Mortality associated with attention- deficit hyperactivity disorder (ADHD) drug treatment: a retrospective … Drug Saf; 2009;32(11):1089-1110 McCarthy S, Cranswick N, Potts L, Taylor E, Wong IC. … Drug Saf. 2009;32(11):1089-1110 McGoey KE, DuPaul GJ, Haley E, Shelton TL.

31. 6 Tk1 T5-Suspect A Urinary Tract Infection Brochure Ma Coalition Final (pdf file)
    www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/nhguide/6_TK1_T5-Suspect_a_Urinary_Tract_Infection_brochure_MA_Coalition_final.pdf
    June 18, 2015 - Sometimes antibiotics can: »Lead to a drug interaction, where one of your medications could become … When resistance occurs, it can be harder to find the right drug to treat an infection.

32. Number of Newborns with Neonatal Abstinence Syndrome Continued To Increase Through 2016 | Agency for Healthcare Research and Quality
    www.qualitymeasures.ahrq.gov/data/infographics/neonatal-abstinence-syndrome-2016.html
    July 01, 2019 - Text Description: The number of babies born each year with withdrawal symptoms from their mother’s drug … In 2016, more than 25,000 babies were born with withdrawal symptoms from drug dependence compared with

33. Declines in Hospital-Acquired Conditions | Agency for Healthcare Research and Quality
    www.qualitymeasures.ahrq.gov/data/infographics/hac-rates_2019.html
    July 01, 2020 - 11.1 MB) Text Description: National efforts to reduce hospital-acquired conditions such as adverse drug … Specific rates are: Adverse drug events: 28% decrease. CAUTI: 5% decrease. CLABSI: 6% decrease.

34. Health Literacy in Pharmacy: Introduction | Agency for Healthcare Research and Quality
    www.qualitymeasures.ahrq.gov/health-literacy/professional-training/pharmacy/resources/slides/intro.html
    September 01, 2020 - Failure to recognize side effects or drug interactions. … Understanding of drug mechanisms and side effects: Warfarin works by thinning blood - 70% correct. … Literacy and misunderstanding prescription drug labels. … Failure to recognize side effects or drug interactions. … Literacy and misunderstanding prescription drug labels.

35. CHIPRA 212 Appendix 2 (pdf file)
    www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-212-appendix-2.pdf
    January 17, 2024 - 2 APPENDIX 2 - INHALED CORTICOSTEROIDS (ICS) ICS NDC Code Brand Name Generic Product Name Route Drug … inhalation d05262 DPI 4 and older N N N Y ICS NDC Code Brand Name Generic Product Name Route Drug … inhalation d01296 DPI 4 and older N N N Y ICS NDC Code Brand Name Generic Product Name Route Drug … inhalation d04276 DPI 6 and older N N N Y ICS NDC Code Brand Name Generic Product Name Route Drug … inhalation d00760 MDI 5 and older Y Y N Y ICS NDC Code Brand Name Generic Product Name Route Drug

36. 3 Tk1 T5-Draft Policies And Procedures For The Antimicrobial Stewardship Program Final (doc file)
    www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/nhguide/3_TK1_T5-Draft_Policies_and_Procedures_for_the_Antimicrobial_Stewardship_Program_final.docx
    October 01, 2016 - The adverse consequences of unnecessary antibiotic use include adverse drug reactions or interactions … , the development of Clostridium difficile infections, the emergence of multi-drug resistant organisms … and overuse of newer, broad-spectrum antibiotics when either no antibiotic or an older narrowspectrum drug

37. When Do You Need An Antibiotic? (pdf file)
    www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/quality-resources/tools/cauti-ltc/modules/resources/tools/reduce/when-need-antibiotic.pdf
    March 01, 2017 - When Do You Need An Antibiotic? When Do You Need An Antibiotic? Taking antibiotics when you don’t need them is like leaving the lights on all the time. The lights may burn out, leaving you in the dark when you most need them. If you use antibiotics when you don’t need them, they may not work when you get s…

38. Program-Dev-Facilitator-Guide (doc file)
    www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/antibiotic-use/long-term-care/program-dev-facilitator-guide.docx
    June 01, 2021 - Also, he does not consider the possibility for potential drug-drug interactions with the resident’s existing … antibiotic therapy is indicated · No stop date on the antibiotic · No post-prescription monitoring for drug-drug … One is to monitor for drug-drug interactions related to antibiotics. … team, you decide to collect data on the following information: To evaluate baseline monitoring for drug-drug … · There’s no indication based on chart review that anyone considered the potential for drug-drug

39. Timely Antiobiotics for Children With Severe Sepesis or Septic Shock Technical Specifications (pdf file)
    www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0230-sepsis-antibiotics-technical-specs.pdf
    August 01, 2014 - hypotension) < 5th percentile for age or systolic BP < 2 SD below normal for age OR • Need for vasoactive drug … dysfunction 995.94 Bacteremia 790.7 Septic shock 785.52 Table 4-C: Parenteral Antibiotics Drug … Class Drug Aminoglycosides Amikacin Sulfate Gentamicin Kanamycin A Sulfate Tobramycin Sulfate … of Antibiotics for Severe Sepsis and Septic Shock U18HS020516 Page 50 Submitted August 2014 Drug … Class Drug Oxazolidinones Linezolid Penicillins Ampicillin Oxacillin Penicillin G Nafcillin

40. 1b.4_Input_File_Specifications_508 (xls file)
    www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/toolkits/input-file-specifications.xlsx
    January 01, 2014 - patient was at the time the prescription was filled yes numeric Blank national_drug_code National Drug … unique identifier yes text or numeric Blank End of Table HEDIS NDC Variables HEDIS National Drug … Code (NDC) Variables Reference Name Concept Description Variable Type Note NDC_CODE National Drug … text From HEDIS Data set of asthma-related medications for data year DESCRIPTION Description of the drug … HEDIS Data set of asthma-related medications for data year DRUG_ID Unique identifier of the primary drug